Liver Cirrhosis Epidemiology Forecast

DelveInsight's 'Liver Cirrhosis - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Liver Cirrhosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Liver Cirrhosis Understanding

The DelveInsight Liver Cirrhosis epidemiology report gives a thorough understanding of the Liver Cirrhosis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Liver Cirrhosis in the US, Europe, and Japan. The report covers the detailed information of the Liver Cirrhosis epidemiology scenario in seven major countries (US, EU5, and Japan).


Liver Cirrhosis Epidemiology Perspective by DelveInsight

The Liver Cirrhosis epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Liver Cirrhosis epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Liver Cirrhosis epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Liver Cirrhosis Detailed Epidemiology Segmentation

The Liver Cirrhosis epidemiology covered in the report provides historical as well as forecasted Liver Cirrhosis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Liver Cirrhosis report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Liver Cirrhosis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Liver Cirrhosis Epidemiology Report and Model provide an overview of the risk factors and global trends of Liver Cirrhosis in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Liver Cirrhosis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Liver Cirrhosis
  • The report provides the segmentation of the Liver Cirrhosis epidemiology


Report Highlights

  • 11-Year Forecast of Liver Cirrhosis epidemiology
  • 7MM Coverage
  • Total Cases of Liver Cirrhosis
  • Total Cases of Liver Cirrhosis according to segmentation
  • Diagnosed cases of Liver Cirrhosis


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Liver Cirrhosis?
  • What are the key findings pertaining to the Liver Cirrhosis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Liver Cirrhosis across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Liver Cirrhosis?
  • What are the currently available treatments of Liver Cirrhosis?


Reasons to buy

  • The Liver Cirrhosis Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Liver Cirrhosis market
  • Quantify patient populations in the global Liver Cirrhosis market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Liver Cirrhosis therapeutics in each of the markets covered
  • Understand the magnitude of Liver Cirrhosis population by its epidemiology
  • The Liver Cirrhosis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Liver Cirrhosis

3. Liver Cirrhosis: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Liver Cirrhosis Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Liver Cirrhosis Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Liver Cirrhosis Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Liver Cirrhosis Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Liver Cirrhosis Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Liver Cirrhosis Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Liver Cirrhosis Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Liver Cirrhosis Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Liver Cirrhosis Treatment and Management

6.2. Liver Cirrhosis Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Liver Cirrhosis Epidemiology in 7MM (2017-2030)

Table 2 Liver Cirrhosis Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Liver Cirrhosis Epidemiology in the United States (2017-2030)

Table 4 Liver Cirrhosis Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Liver Cirrhosis Epidemiology in Germany (2017-2030)

Table 6 Liver Cirrhosis Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Liver Cirrhosis Epidemiology in France (2017-2030)

Table 8 Liver Cirrhosis Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Liver Cirrhosis Epidemiology in Italy (2017-2030)

Table 10 Liver Cirrhosis Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Liver Cirrhosis Epidemiology in Spain (2017-2030)

Table 12 Liver Cirrhosis Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Liver Cirrhosis Epidemiology in the United Kingdom (2017-2030)

Table 14 Liver Cirrhosis Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Liver Cirrhosis Epidemiology in Japan (2017-2030)

Table 16 Liver Cirrhosis Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Liver Cirrhosis Epidemiology in 7MM (2017-2030)

Figure 2 Liver Cirrhosis Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Liver Cirrhosis Epidemiology in the United States (2017-2030)

Figure 4 Liver Cirrhosis Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Liver Cirrhosis Epidemiology in Germany (2017-2030)

Figure 6 Liver Cirrhosis Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Liver Cirrhosis Epidemiology in France (2017-2030)

Figure 8 Liver Cirrhosis Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Liver Cirrhosis Epidemiology in Italy (2017-2030)

Figure 10 Liver Cirrhosis Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Liver Cirrhosis Epidemiology in Spain (2017-2030)

Figure 12 Liver Cirrhosis Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Liver Cirrhosis Epidemiology in the United Kingdom (2017-2030)

Figure 14 Liver Cirrhosis Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Liver Cirrhosis Epidemiology in Japan (2017-2030)

Figure 16 Liver Cirrhosis Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Liver Cirrhosis Epidemiology
  • Liver Cirrhosis
  • Liver Cirrhosis Pipeline
  • Liver Cirrhosis Companies
  • Liver Cirrhosis prevalent populati...
  • Liver Cirrhosis incident populatio...
  • Liver Cirrhosis patients diagnosed
  • Liver Cirrhosis treatment algorith...

Forward to Friend

Need A Quote